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CONTRACEPTION: PAST, PRESENT, AND FUTURE 
ESHERE GBARBEA 
 
ABSTRACT 
 
 The most common method of birth control used since 3000 B.C., is the condom. It 
has been used continuously in the 21
st
 century but several other forms have been added. 
Due to reformers like Marie Stopes, Margret Sanger, Katharine McCormick and Gregory 
Pincus contraceptive usage has become popularized in today’s society. New forms of 
contraceptive include but are not limited to intrauterine devices (IUDs), shots, pill, patch, 
and vaginal rings. These devices have been developed as both hormonal and non-
hormonal products.  Hormonal birth control delivers hormones such as estrogen and 
progestin, which affect the joining of the sperm and egg. Products that are non-hormonal 
are a viable alternative for women who cannot tolerate hormonal regulation.   
Estrogen and progestin function as contraceptives by changing various areas in 
the vaginal tract by changes such as the thickening of cervical mucus, thinning the uterus 
lining, or increasing the vagina acidity. Researchers are also trying to develop other 
options such as a male contraceptive option to expand and reach a target population that 
is not currently reached.  
There are also government policies currently in Congress that address the issue of 
the uninsured; thereby reaching those who may need contraceptives the most.  The 
Affordable Care Act also known as Obama care is trying to provide Medicaid to people 
  vi 
who do not and would not ever be able to afford adequate health care, including 
contraceptives on their own. With the passing of the Affordable Care Act more women 
will be able to go to a medical provider to be informed and educated on the various 
contraceptive methods, enabling them to make an informed decision. 
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INTRODUCTION 
 
History 
Birth control methods have been around for many years. The earliest time period 
known to use birth control was around 3000 B.C. (Christin-Maitre, 2013). The most 
common method used by Egyptians was condoms. Egyptians developed vaginal pessaries 
as well as vaginal sponges. Pessaries were like a cotton tampon used to prevent 
pregnancies. They were made out of crocodile dung, honey, and sodium bicarbonate and 
were then soaked in fermented juice of acacia plants. Vaginal sponges were used as 
spermicides and were soaked in lemon juice or vinegar (Christin-Maitre, 2013).  
After the Egyptian the next recorded record came from the Greeks (Christin-Maitre, 
2013). Around the fourth century B.C., Aristotle wrote about anointing a woman with 
olive oil to prevent pregnancy and exerting pressure on their abdomen to expel semen 
from the vagina. Plants during this time period were also recorded to have certain 
properties to hinder a woman's ability to conceive and included plants such as 
pomegranate, pennyroyal, and pine. The Catholic Church in 1276 also offered ways to 
induce menstruation. Women in Sri Lanka were recorded to eat one papaya a day as it 
was thought that the enzyme papain contained within the papaya interacted and affected 
progesterone levels (Christin-Maitre, 2013).  
The Chinese had their own ideas on how to prevent pregnancies. The women were 
instructed to drink lead and mercury to inhibit implantation (Christin-Maitre, 2013). But 
 2 
 
 
the side effects of the chemicals far outweighed the benefits because they lead to sterility 
and. In the 16
th
 century, Europeans used condoms made from fish or animal gut, to 
prevent syphilis and pregnancy. Fortunately, in 1944, Charles Goodyear invented the 
patented vulcanization of rubber which is now used in many condoms and diaphragms. 
Throughout these time periods several forms of birth control methods have come into 
being. Approaches such as abstinence, condoms, IUDs (intrauterine devices), 
breastfeeding, coitus (the pull out method), infrequent coitus (infrequent sexual 
intercourse), pills, and induced abortion were utilized (Christin-Maitre, 2013).  
From the beginning of the 20
th
 century there have been many improvements made. 
These changes/improvements can be credited to  many men and women involved in 
researching and advocating for the use of birth control (Christin-Maitre, 2013). The major 
players in the development of birth control included Dr. Marie Stopes from Scotland 
(Christin-Maitre, 2013). She wrote the book called Wise Parenthood and opened her first 
birth control clinics in Holloway, north London, in 1921. The dawning of hormonal 
methods was conceived by Margaret Sanger, Katharine McCormick and Gregory Pincus 
(Stopes, 2006) 
 Due to the Comstock act of 1873 posed in US Supreme Court prohibiting 
advertisement, information and distribution of birth control, and allowing the postal 
service to confiscate birth control through the mail, it was really difficult for individuals 
to receive what was needed in the states (Christin-Maitre, 2013). This all changed in 1916 
when Margaret Sanger founded the American Birth Control League and opened up 
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Planned Parenthood (Baker, 2011). She has said “No women can call herself free who 
does not own and control her body (About Education, n.d.). No women can call herself 
free until she can choose consciously whether she will or will not be a mother.  Her 
movement was inspired by her mother’s experience with pregnancy. Her mother was 
pregnant 18 times and had birthed 11 children and died at the early age of 50 (Christin-
Maitre, 2013). 
 A year after the opening of her clinic, Sanger was arrested and sent to jail for 30 days 
for the crime of maintaining a public nuisance. Once Sanger was released she reopened 
her clinic and suffered additional prosecution. In 1938, with the help of Sanger, the 
Comstock case was reversed, lifting the ban on birth control  (Our Bodies Our Selves, 
n.d.). In the 1950s Sanger, along with her woman’s right partner Katharine McCormick 
helped to create the first human birth control pill (Christin-Maitre, 2013). Katharine 
McCormick was the wife of the person who invented the mechanical harvester. She 
helped fund Gregory Pincus research into developing the pill. Gregory Pincus was the 
creator of the first contraceptive pill (Christin-Maitre, 2013).  
McCormick also funded the first clinical trial ran by Dr. John Rock who was the co-
developer of the pill (Christin-Maitre, 2013). Along with the help of Sanger staff of 
Planned Parenthood, he wrote a book called “The Time Has Come: A Catholic Doctor 
Proposal to End the Battle over Birth Control” (Rock, 1963).  Dr. Rock used Carl 
Djerassi’s a researcher on steroids, when developing the pill (Marks, 2001). Carl Djerassi 
had synthesized a progestin known as norethisterone which was found to be stronger than 
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the natural progesterone. So strong that doses over 5mg of progestin in a 21 day regimen 
led to the suppression of ovulation as well as caused an unacceptable amount of bleeding. 
To stop the bleeding it had to be combined with mestranol (Ravina, 2011).  
Along with that discovery mestranol, its active metabolite, ethinyl estradiol (EE) and 
norethisterone were added to the contraceptive pill (Christin-Maitre, 2013). These three 
ingredients made up the first pill Enovid, a combined oral contraceptive. It was approved 
by the FDA in 1957 and used treat menstrual disorders, but soon people started noticing 
that it helped to prevent pregnancy as well (The Embryo Project Encyclopedia, n.d.). 
With this discovery, in 1959 the pharmaceutical company Searle went to the FDA to 
approve the pill being marketed as an oral contraceptive (Our Bodies Our Selves, n.d.). 
The next year it was approved. In 1968, the use of IUDs was approved coming out with 
earlier versions such as the copper 7. 
By 1972, birth control had become legalized for all American citizens, even those 
unmarried. Finally, by the 1990 and early 2000 methods we are now so familiar with 
more option that have been invented. Things like the first contraceptive implant, Depo-
Provera an interjectable contraceptive, Fc1,  the female condom, and lastly Plan- B the 
emergency contraceptive (Our Bodies Our Selves, n.d.). 
The purpose of this thesis is to inform and educate women on the importance of 
awareness when choosing a birth control option. Additionally, current and future studies 
on the topic will be discussed, while reporting on their effectiveness and failure rates. 
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Methods of Birth Control 
There are several methods of birth control in practice along with abstinence and 
breastfeeding. They can be separated into two groups. The first group is the reversible 
method and the second is the permanent method. In the reversible group are intrauterine 
contraceptives, the hormonal methods, barrier methods, and the fertility awareness-based 
methods.  The permanent method includes sterilization (female and male) and 
vasectomies. 
We have all been told that the safest and the most effective way to prevent pregnancy 
is through abstinence (“Birth Control Methods - Birth Co. Some, however, may be 
confused on just what that entitles.  The correct way of abstinence is to abstain from all 
forms of sexual play. These include oral, anal, and vaginal activities (“Planned 
Parenthood,” n.d.). 
Breastfeeding can help to prevent pregnancy because the constant act helps to change 
a woman’s hormone so that ovulation does not occur. Without ovulation there is no egg 
and without the release of an egg pregnancy cannot occur (Planned Parenthood, n.d.). 
Long Acting Reversible Methods-Intrauterine Contraception 
IUD’s are a small t-shaped device that can be inserted into the vagina by a health 
care provider and can last for up to 12 years (Planned Parenthood, n.d.).). This method 
does not rely on the user adherence because once inserted they must consult with a 
healthcare provider to discontinue (Mestad et al., 2011). There are three types of IUDs 
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approved for use within the United States. The first is a copper based IUD also known as 
Paragard® created by the Teva Women’s Health, INC, Cincinnati, OH (Mestad et al., 
2011). The second is a hormonal type called Levonorgestrel (Mestad et al., 2011). The 
brand on the market is known as Mirena® (5 yrs) or sometimes Skylar® (3 yrs) 
(“Planned Parenthood,” n.d.). The last one is the etonogestreal sub dermal implant also 
known as Implanon® (Mestad et al., 2011).. 
Paragard® can be used as an emergency contraception if inserted within five 
years (Planned Parenthood, n.d.).). Upon insertion of the copper intrauterine device, the 
copper ions are slowly released into the uterine and tubal fluid where it has both a pre and 
post fertilization effect (Mestad et al., 2011). The copper IUD composition can be toxic 
to both the ovum and the sperm, thus leading to a major impact on the pre-fertilization 
stage (Koyama, Hagopian, & Linden, 2013). This can occur even after fertilization has 
taken place and before the embryo enters the uterus (Koyama et al., 2013).  The resulting 
effect includes a toxic oocyte, impairment of sperm function (including motility, 
viability, acrosome reaction, fertilizing capacity, and influence on tubal motility) and the 
fertilization process (Mestad et al., 2011). If fertilization does occur then the IUD leads to 
a local inflammatory reaction in the endometrium that causes the release of cytokines and 
integrin’s which can inhibit implantation (Koyama et al., 2013). 
The hormonal IUD releases a small amount of progestin (Planned Parenthood, 
n.d.). The difference with the Levonorgestrel (LNG) IUD is that it can be used while a 
mother is breastfeeding without impacting the infant (Mestad et al., 2011). The 
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mechanism of action for this devise relays on a paracrine action.  LNG is held within the 
cylinder of the plastic device that is coated by a membrane that can control the release 
and the dosage of the drug (Mestad et al., 2011).   
The drug Mirena® releases at a rate of the 20µg / day when first inserted, after 
five years it decreases to a rate of 14 µg/day (Mestad et al., 2011). Skyla® releases at a 
rate of 14 µg/day and slowly decreases to a rate of 5 µg/day after three years. Even 
though the rates decrease, it still functions at a clinically effective rate. LNG acts similar 
to the copper IUD in that they both help to hinder per fertilization (Mestad et al., 2011).  
Reversible Methods- Hormonal Method 
The first reversible method is the contraceptive implant. The implant is a thin, 
flexible, plastic device that can be inserted underneath the skin of the upper arm (Planned 
Parenthood, n.d.). It is tubular and approximately 40mm long (Choices, 2015). This then 
constantly release small amounts of progestin ensuring prevention of pregnancy for up to 
three years ((Planned Parenthood, n.d.). The mechanism that enables the implant to 
effectively prevent pregnancies is through the hormonal release of progesterone that is 
transported within the blood stream (Choices, 2015). The released synthetic progesterone 
acts similar to the natural one. It then stops the release of the ovum from the ovaries, 
thickens the cervical mucus and thins the womb lining. This results in the sperm’s 
inability to move through the cervix and thus less likely to accept a fertilized egg. The 
contraceptive implant has been proven to be 99% effective. Studies have shown that less 
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than 1 in 1000 women get pregnant in one year. It is easily removed, resulting in the 
return of the natural cycle Figure 3 (Choices, 2015). 
The most common types on the market today are Nexplanon® and Implanon® 
(Planned Parenthood, n.d.). Implanon® was commonly used before October 2010 but 
became less installed after Nexplanon® was created (Choices, 2015). Both implants work 
in similar manners with the only difference being that Nexplanon® decreases the risk of 
insertion errors, is visible on X-rays and CT’s scans, and can be used until the age of 
menopause. The implant can be inserted at any time during the menstrual cycle. If 
inserted during the first five days of the cycle it can result in an immediate protection 
against pregnancy (Figure 1). If installed any time after it will take up to five days for the 
implant to become effective (Choices, 2015).  
 
Figure 1: IUD placement. Shown is the different IUDs and how they are inserted. Take from Loren, 2011. 
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The installation of the contraceptive implant may cause a general infection at the 
application site which can be treated with basic antibiotics (Choices, 2015). The bodily 
effects include headaches, acne, nausea, breast tenderness, changes in mood, loss of sex 
drive, and weight gain. The implant can also have a chemical cross reaction with other 
prescriptions taken by the individual. Some examples include enzyme inducing drugs 
such as HIV (human immunodeficiency virus) and epilepsy medications, St. Johns Wart 
remedies, rifabutin (an antibiotic that treats tuberculosis (TB)), and rifampicin (antibiotic 
that treats TB and meningitis). If a patient is on these medications, it is recommended to 
use an additional, contraceptive (condoms/shot) during treatment and 28 days after 
treatment (Choices, 2015).  
The second hormonal method is the contraceptive shot. It is an injection that contains 
the hormone progestin (“Planned Parenthood,” n.d.). It can prevent pregnancy for up to 
three months. Brand on the market known as Depo-Proverar® or sometimes DMPA 
(Planned Parenthood, n.d.).  
The shot can be given into the buttocks and upper arm  and helps to prevent ovulation 
when it is taken on schedule with an effectiveness of 99% if applied on time (Carlson, 
Eisenstat, & Ziporyn, 2004). The hormone is also reversible and can easily be removed 
from the body. The shot is administered by a clinician four times a year. Once the shot is 
given the active ingredient medroxyprogesterone acetate or MPA is released. MPA is 
chemically similar to progesterone (Carlson et al., 2004).  
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The shot costs approximately 30 to 75 dollars excluding doctor’s visit (Carlson et al., 
2004). In order to receive the first shot, a full physical examination is required. Once 
cleared by physical examination, the shot can be given the first five days following 
completion of the menstrual cycle. This is to ensure that the woman is not pregnant. It 
can also be given to mothers who just delivered and chose not to breast feed given within 
five days of child birth (Carlson et al., 2004).  
There are many effects associated with the shot, such as an irregular vaginal bleeding 
and weight gain (Carlson et al., 2004). It was shown that one third of women get irregular 
bleeding for the first three months and eventually decreases overtime.  With the increase 
in weight gain it was shown to be not as common as the pill. Researchers found that with 
an increase in years of usage there is an increase in weight. At two years usage there’s an 
eight pound gain (4 per year), four years usage has a fourteen pound gain (3.5 per year), 
and six year usage found  a 16.5 gain ( 2.75 per year) (Carlson et al., 2004).  
Other effects include a complete menstrual stop, depression, and osteoporosis 
(Carlson et al., 2004). Osteoporosis can lead to a decrease in bone density after five years 
and is only seen in women who smoked. Osteoporosis can be reversible but if it occurs in 
adolescents it can have long term effects. The shot is not recommended for those with a 
history of liver disease, major depression, as well as women who are pregnant and have 
unexplained bleeding where the origin cannot determined (Carlson et al., 2004).  
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If breast feeding, it is important for new mothers to wait  six weeks  after child birth 
for the first injection due to passage through the breast milk (Carlson et al., 2004). 
Researchers have not found any side effects in infants. If you want to conceive, stop 
receive the shot and within a year after last dosage. It was shown that 90 percent of 
women become pregnant within the first 18 months (Carlson et al., 2004). 
MPA is insoluble in water so it must be formulated in an aqueous suspension that 
includes PEG and polysorbate 80, along with their preservatives methylparaben and 
popylparaben (Lee & Desai, 2007). Sodium chloride is also included to adjust the tonicity 
of the injection. When injected it forms deposits and has a long half-life due to slow 
absorption from the site. This in turn leads to slow dissolution of the drug.  Within 24 
hours of the shot the concentration is sufficiently high resulting in an immediate 
protection against pregnancies (Lee & Desai, 2007).  
There are two types of the Depo-Provera® shots, Depo-sub Q Provera 
TM 
  and Depo-
Provera® CI that can be classified based on the application of the shot (Lee & Desai, 
2007). The Depo-sub Q Provera 
TM 
  shot is a subcutaneous (SC) progestin only injection 
that is available in prefilled syringes. The syringes need to be shaken well for a 
disbursement of the drug, once injected MPA is absorbed and reaches a steady state 
concentration after multiple injections into the abdomen or anterior thigh. The shot 
should be administer every 12 to 14 weeks with a dosage of 104mg of MPA per dose. At 
the injection site it’s slowly released resulting in a low blood concentration. This shot 
should be used given to women who cannot tolerate estrogen (Lee & Desai, 2007). 
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Depo-Provera® CI is a contraceptive injection that is inserted into the intermuscular 
(Lee & Desai, 2007). It is injected every twelve weeks into the deltoid or gluteal muscle. 
It comes in vials and prefilled syringes that need to be shaken to ensure a uniform 
suspension of the drug. The MPA in this shot has a half-life of 50 days and reaches a 
steady state concentration of 150mg per dose and reaches peek at three weeks. The 
dosage distribution includes 1-7 ng/ml at the peak, 1 ng/ml maintained at 3 months, 0.2 
ng/ml at 5-6 months, at 6 months effectiveness is lowered and another shot is required 
(Lee & Desai, 2007) .  
Combined Oral Contraceptives: Often contraceptives are a combination of hormones that 
are taken daily and act as an oral contraceptive method (Planned Parenthood, n.d.).  
These can be made from having both estrogen and progestin or only progestin. The pill 
keeps the egg from leaving the ovaries and makes the cervical mucus thicker ensuring 
that sperm do not reach the egg  
The Patch:  The patch is a thin, beige, plastic that can adhere to the skin (Planned 
Parenthood,  n.d.). The design of the patch is specific to be water and sweet proof (Bell, 
n.d.). It can be adhered to the abdomen, buttocks, upper arm and torso. When applied it is 
important to never apply soap or skin products such as lotion or oil to the area due to it 
effecting the ability to stick (Bell, n.d.).  
The patch is worn for 3 weeks in a row and then removed for the last remaining 
week. The patch must be worn for seven days and changed on the eighth day (Helms & 
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Quan, 2006). Mistakes as we know do occur, therefore if the patch falls off for less than 
24 hours it can be easily reapplied without the need of using a backup birth control 
method. However, if it is more than 24 hours a new patch must be reapplied thus resetting 
to a new patch cycle (Helms & Quan, 2006). It is important to pick a specific day (such 
as Monday) where you can always ensure application (Bell, n.d.). This is to make sure 
seven days have passed before applying a new patch. On the market now is the Xulane® 
(Planned Parenthood, n.d.). 
The patch releases both progestin and estrogen (Bell, n.d.). The chemicals 
released from the patch works by preventing ovulation, thickening the cervical mucosa, 
and thinning out the uterus to hinder attachment. If you are a first time user, it is 
important to use a backup contraceptive during the first seven days, just as a failsafe. 
Medical experts do not prescribe users to be over the age of 35 and if they had risk of 
blood clots chest pains, diabetes, high blood pressure, headaches, a known suspected 
tumor, hepatitis, heart disease, or if they are allergic. The patch may also have drug 
interactions with certain antibiotics that are used to treat seizures, migraines and 
tuberculosis (Bell, n.d.).  
Smokers are advised not to use the patch due to an increase in blood clots, 
strokes, and heart attacks (Carlson et al., 2004).  The patch is made by Orthoevra® in 
2002 and can also be referred to as the transdermal patch. Another side effect occurs to 
contact wearers who experience an increase in blurry vision and the inability to wear 
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contacts. The patch cost approximately 30 to 35 dollars per month, this however does not 
include the medical examination fees (Carlson et al., 2004). 
The patch is infused with a total concentration of 6.75mg of progestin 
norelgestromin and estrogen ethinyl estradiol (Helms & Quan, 2006). The daily dosage 
delivers 0.15mg per day for progestin norelgestromin and 20 µg per day for estrogen 
ethinyl estradiol. When the patch is adhered, chemicals travel transdermal through the 
skin. Once absorbed the norelgestromin is metabolized to active progestin norgestimate. 
It must be applied the first day of a woman’s menses or the Sunday following (to ensure 
consistence) (Helms & Quan, 2006).  
The next side effect reported during clinical trials is a 9-20 percent chance of 
developing breast symptoms, headaches, allergic reactions, nausea, upper respiratory 
infections, menstrual cramps, ad abdominal pains (Helms & Quan, 2006). 
The Vaginal Ring: There are many advantages to using the vaginal ring as a 
contraceptive method including the consistent and constant delivery of steroid hormones 
(Johansson & Sitruk-Ware, 2004). The hormone is absorbed through the epithelium in a 
rapid and constant rate. This method allows for the delivery of natural steroids. Another 
advantage of the ring is that it can be easily controlled by the user with accessible 
insertion and removal techniques. This allows for easy removability during sexual 
intercourse for up to 2 hours. This is compared to the IUD and other hormonal implants 
where a health care provider has to implant the devices (Johansson & Sitruk-Ware, 2004).  
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 The hormone contained in the rings, first contained a low dose estradiol 
(Johansson & Sitruk-Ware, 2004). This was first developed by the pharmaceutical 
company Pharmacia for a local estrogen deficiency problem (Holmgren, Lindskog, & 
von Shoultz, 1989). It was then developed to include a estradiol ester (EE) ring for 
menopausal women by Galen Pharmaceutics (Johansson & Sitruk-Ware, 2004). Today, 
technology and formulations have been used to allow for a more efficient, safe, rational, 
and sleek design (Johansson & Sitruk-Ware, 2004).  
The design of the ring is a small, flexible, ring that is inserted once a month to 
release small amounts of progestin and estrogen (Planned Parenthood, n.d.).  Figure 2 
shows the Population Council’s combination estrogen/progestin ring which contains the 
synthetic progestin Nestorone (16-methylene-17alpha-acetoxyl-19-nor-pregn-4-ene-3, 20 
dione) plus the synthetic estrogen, ethinyl estradiol (EE) (Johansson & Sitruk-Ware, 
2004).  
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Figure 2:  Diagram of the Nestrone / Ethinyl Estradiol Contraceptive Vaginal Ring.  Abbreviations:  
Norestrong/ethinyl estradiod  - NES/EE. (Johansson & Sitruk-Ware, 2004) 
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This vaginal ring can be left in place for three out of four weeks and removed for 
the remaining week (Planned Parenthood, n.d.). This helps to prevent. For women who 
are wanting to prevent pregnancy the use of a combination contraceptive ring is the best 
(Johansson & Sitruk-Ware, 2004). The use of estrogen and progestin as used in the oral 
formulation is widely considered the optimal hormonal contraceptive method (Johansson 
& Sitruk-Ware, 2004).  
Recent FDA approval for vaginal rings contain etonogestrel/EE (Johansson & 
Sitruk-Ware, 2004). These are the Nuva® ring, Organon USA, Roseland, N.J, which is 
available to women in the US. The Population Council developed a ring to release a 
combo of progestin and estrogen, which contained norethindrone acetate (NETA) and 
EE. This was originally used for three months periods, but was reformulated to last for 
twelve months. However, due to a finding that it caused ovulation problems it was 
discontinued and another formula was made. The new formula contained a synthetic 
progestin Nestorone along with a synthetic estrogen ethyl estradiol (EE) known as NES. 
NES is a progestational agent that is derived from 19-norprogesterone which can be more 
potent than its counterpart levonorgestrel. With the NES and EE developed by the council 
it was made effective for 12 months (Johansson & Sitruk-Ware, 2004).  
The hormones are implanted within the core of the ring and are released with the 
range of three weeks to one year (Johansson & Sitruk-Ware, 2004). It is taken up by the 
skin and the vaginal epithelial membrane easily (Alvarez-Sanchez, Brache, Jackanicz, & 
Faundes, 1992). The steroid in the ring is within two rods where one contains NES alone 
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and the other has both NES and EE (Alvarez-Sanchez et al., 1992).  The Population 
Council is trying to identify a competitively priced, long term contraceptive method that 
will remain active for the longest duration which is extremely important for developing 
countries (Johansson & Sitruk-Ware, 2004). 
There are other rings in development, including a progesterone-only ring, a steadily 
released progesterone that is intended for contraceptive use (Johansson & Sitruk-Ware, 
2004). However, it cannot be used by women that are breast feeding because the use of 
steroids can lead to exposure of the newborn infant via breast milk (Johansson & Sitruk-
Ware, 2004). This new ring can be as effective at preventing pregnancy as the copper T-
shaped IUD (Zegers-Hochschild et al., 2000). It can also be used for progesterone therapy 
during  in vitro fertilization (IVF) (Sivin et al., 1997).    
Emergency Contraception Pills  
Emergency contraception pills are used to prevent pregnancy for up to five days 
after unprotected sex (Planned Parenthood, n.d.). There are two types, the morning after 
pill and the Paragard® IUD insertion. There are also two types of pills. The first is the 
levonorgestrel (LNG) pill which is most commonly known as Plan B® and the ulipristal 
acetate pill, also known as the Ella®.  
The LNG is a progestin-only pill that suppresses ovulation by delaying the 
luteinizing hormone (LH) surge (Figure 3) (Koyama et al., 2013). It must be taken before 
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the surge begins. When the pill is taken closer to the ovulation time it can be less 
effective (Koyama et al., 2013).  
 
Figure 3: Menstrual Cycle. Shown is the progression of hormones and its affect in the uterus. (Koyama et 
al., 2013). 
 
 
 The Ella® pill keeps a women’s ovary from releasing an egg for longer than usual 
(Planned Parenthood, n.d.). It is also known as Ulipristal® and is used after unprotected 
sexual intercourse occurs (“Ella (Emergency Contraceptive) - Drugs.com,” n.d.). It is not 
intended to be used as a regular form of birth control. Ella has been known to cause harm 
to an unborn baby or cause birth defects. With this information it is important to note 
when a woman’s menstrual period occurred to make sure that pregnancy has not been 
established (“Ella (Emergency Contraceptive) - Drugs.com,” n.d.). 
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Emergency contraceptives cause alterations in hormone levels and changes in 
menstrual bleeding (Table 2) (Koyama et al., 2013).  The side effects from the dosage 
leads to a mild nausea, vomiting, and headaches. When comparing the Yuzpe® and the 
LNG  pill methods, the Yuzpe® method had the highest incidence of side effects 
(including nausea and vomiting) while the LNG had absolute no contraindication 
(pregnancies). The LNG pill was shown to be well tolerated with nause at 2% and 
vomiting in 5.6%.  Less common side effects include fatigue, dizziness, headaches, 
mastalgin, and disruptions in the menstrual cycle (Koyama et al., 2013). 
Reversible Method- Barrier Method 
The Sponge is a soft, round, plastic foam that contains spermicides that are constantly 
released. The sponge can be infused with a spermicide called nonoxyol-9®  which helps 
to maintain an inhospitable acidity within the vagina (Holmes, Hoskins, & Gross, 1980).  
The foam is made from polyurethane and has a nylon loop attached for easy removal 
(Vincent & Greenberger, 2012). It can be inserted before intercourse and keeps sperm 
from joining the egg by covering the cervix and blocking the uterus (“Planned 
Parenthood,” n.d.).  
 When inserting the sponge it is best to insert upside down with the loop facing 
towards the outside of the vagina for easily removal (Vincent & Greenberger, 2012). The 
sponge can be inserted before any sexual activity and remain in place for repeated 
activity for a 24 hour time period (must not be kept in for more than 30 hour after 
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insertion). Also, after activity must be removed a minimum time period of 6 hours after 
sex (Vincent & Greenberger, 2012).  
For cleaning, the sponge can be washed repeatedly and reused. The washing 
solution can be a simple buffer salt solution (Holmes et al., 1980). There have been 
problem associated with usage of the sponge. The sponge does not protect against STDs 
and STIs (Vincent & Greenberger, 2012). It has been found to be 89-91% effective for 
certain women. However, in women who have had children it has been shown to be less 
effective (Vincent & Greenberger, 2012).  
The advantages of using the sponge method as a birth control alternative is that it 
is easy to carry and use, can be inserted for 24 hours, is immediately effective, it doesn’t 
affect fertility, can’t be felt by the woman or partner once inserted, and lastly can be used 
by women breastfeeding (Hales, 2008). The disadvantage of the sponge includes 
difficultly to remove, less effective if they have had children, doesn’t protect against 
STDs and STIs, requires an advance planning in order to place causes irritations and 
toxic shock syndrome (Hales, 2008). 
 Some cases have had expulsion during bowel movement and the development of 
odors after intercourse or menstruation (Holmes et al., 1980).  Side effects of using the 
sponge includes vaginal irrational, allergic reactions, and an increase risk in toxic shock 
syndrome (Hales, 2008).  The sponge is available to the public without a doctor 
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prescription. To hold the sponge in place while in the vagina there are depression that 
hold onto the cervix (Hales, 2008).  
The diaphragm is a shallow, dome-shaped cap with a flexible rim made from silicone or 
latex (“Planned Parenthood,” n.d.). Used by covering the cervix to block entrance of 
sperm into the uterus. This must be used along with a spermicide (“Planned Parenthood,” 
n.d.). The diaphragm has metal springs in the rims in order to exert pressure on the 
vaginal walls and urethra to stay in place (Hales, 2008). There are nine to ten sizes 
available for fitting at the doctor’s office (Benson, 1998). Size variations can depend on 
weight gain (20 plus/minus pound requires fitting), birth of baby, time of fitting. Can be 
worn for up to 24 hours but no more than that (Benson, 1998).  
 With the various sizes, there needs to be a proper fitting consultation with a 
professional medical advisor where women can be properly educated on how to insert 
and remove the diaphragm (Benson, 1998). This needs to be done because if done the 
improperly it could result in pregnancy.  At the doctor’s visit they teach that the 
diaphragm is to be inserted one hour before intercourse along with the spermicide 
(Benson, 1998). Before insertion fill the diaphragm two-third full with spermicide jelly 
and smear some around the edges (Mucciolo, 2000). Then pick a comfortable position 
(either laying on back with knees up, squatting, or standing with one leg propped up) for 
easy insertion (Mucciolo, 2000).  
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 If inserted more than one hour prior, additional spermicide may be required 
before intercourse is to occur (Benson, 1998). After intercourse, the diaphragm must be 
left in place six to eight hours and if intercourse occurs more than once each time requires 
additional use of the spermicide. If left out in the open for long periods it can dry out and 
crack (Benson, 1998). 
Side effects include a puncture of the latex, vaginal abrasion, increase risk of 
urinary tract infections, and toxic shock syndromes (TSS) (Hales, 2008).  Latex can cause 
allergic reactions and can be easily punctured by fingernails. It can also deteriorate 
quickly if exposed to petroleum products (lubricants, oils) and heat or light.  Diaphragm 
usage needs special care and may cause odors (Hales, 2008).  
 Problems associated with the diaphragm can be a dislodgement with the 
movement of a large bowel movement (Benson, 1998). There are no serious health risks 
but allergic reactions and TSS can occur. The toxic shock syndrome is a bacterial illness 
that can occur in less than 10 women per 100,000 users. Women who decide to use the 
diaphragm need to be aware of the symptoms of TSS. These include a sunburn rash, 
fever, nausea, vomiting, and muscle aches. If two or more of these occur while using the 
diaphragm, immediately seek medical assistance (Benson, 1998). The advantage of using 
this method over the other is that sexual intercourse can occur during a woman’s 
menstrual cycle (Mucciolo, 2000). The diaphragm can block the menstrual flow and 
prevent it from spilling out of vagina. If women do choice to engage it is important to 
keep the device in for more than several hours (Mucciolo, 2000).  
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The Cervical Cap is a silicone cap shaped like a sailor’s hat. It is similar to the diaphragm 
in that it can be inserted to cover the cervix, thus, blocking access of sperm into the 
uterus. This must be used in conjunction with a spermicide. The market brad is known as 
Fem Cap® (“Planned Parenthood,” n.d.). 
The Fem Cap® is a non-hormonal latex free devise that can conform to the 
anatomy of the cervix and vagina (Hales, 2008). The Fem Cap® requires a prescription 
and must be fitted by a health care provider to ensure a proper measurement (Unzeitig & 
Lunsen, 2000). It has to fitted by a physician due to variation of the cervix size, shape, 
and angle in comparison to the vagina (Unzeitig & Lunsen, 2000). It is available in three 
sizes small, medium, and large (Hales, 2008). The small cap is for women who have 
never been pregnant, medium for women who have been pregnant but had an abortion or 
c-section, and large for women who have delivered  full terms babies vaginally (Hales, 
2008).  
There are other changes that are taken into account such as bodily reactions 
during menstruation, ovulation and intercourse(Unzeitig & Lunsen, 2000). During 
intercourse there is a 3-5 cm elongating of the vagina and after ovulation the cervix 
lowers and firms by similar lengths.  While after menstruation the cervix is low in vagina 
and firm to touch. As the cycle progresses the cervix rises higher in the vagina and 
softens in response to an increase in estrogen levels (Unzeitig & Lunsen, 2000).  
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After the doctor’s visit the patient receives two devices, one to be kept at home 
and the other to be place in a purse for easy access (Unzeitig & Lunsen, 2000).  The 
device must be inserted before sexual arousal begins in order to ensuring a proper fitting, 
it should not however be inserted after arousal has begun. This requires pre-planning of 
sexual activities. It can be left in place for a couple of hours for a maximum of 48 hours 
(Unzeitig & Lunsen, 2000). 
During application, apply the spermicide to outer brim and round the edge of the 
side facing into the vagina (Unzeitig & Lunsen, 2000). The cap fits into the fornices of 
the vagina by using contraction causing the brim to adhere and conform to the vaginal 
walls. The Fem Cap® has also been proven to be very durable in that it is made from a 
silicon rubber that can be heated and cooled uniformly. It is also able to withstand 
extreme temperatures and cannot be punctured by fingernails. It is easy to clean, with 
stand petroleum products (lubricant, oils), and does not absorb or cause odors (Unzeitig 
& Lunsen, 2000).  
Male Condom is made of a thin, plastic, latex that helps to protect against sexual 
transmitted diseases (STD), prevent pregnancy and keep sperm away from the egg 
(“Planned Parenthood,” n.d.). The use of condoms can lead to a decrease in the incidence 
and transmission of STDs like HIV (Strauss III & Barbieri, 2013). STDs are transmitted 
by infectious semen, vaginal discharge, infected skin or mucosal surfaces. When applying 
the condom it is important to have a fully erect penis and about half an inch at the tip of 
condom for ejaculation. When removing after intercourse one must be careful of spillage 
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upon withdrawal. Failure rates have been reported to be about 14%. Sexually active 
teenagers have been shown to be the most likely to use condoms (at approximately 60-
80%) (Strauss III & Barbieri, 2013).  
 There are three commonly used materials to make condoms; latex, polyurethane, 
and lamb caecum (Sloane, 2008). Each of the three has its advantages and disadvantage 
over the other. The latex condom has been shown to be better at providing protection 
against vaginal or penal discharges rather than protecting against exposure to skin or 
tissue.  The polyurethane condoms are more prone to slippage but can be stored virtually 
anywhere. Lastly the lamb caecum has small pores that allow viruses and bacteria to pass 
but allows for a natural feeling. Possible side effects condom use include skin irritation, 
abrasions to skin, allergic reaction to latex, and the development of dermatitis from the 
use of lubricants and spermicides. If one of these problems occur, the best solution is to 
try another brand (Sloane, 2008). 
 The male condom is the oldest form of birth control and prevention. It is also the 
least expensive and is readily available (Smith, 1998). The condom comes in a variety of 
colors, textures, flavors, and sizes.  It was designed to fit the average penis size of most 
Americans, which measure at 6.8 inches (17 cm) long, 2 inches (5cm) wide and 0.001 to 
0.004 inches thick.  It can also come lubricated or unlubricated and come with or without 
spermicides. If choosing to use a latex condom it is recommended to use a water-based 
lubricant to limit deterioration. Condom are manufactured based on how there are going 
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to be used. Therefore, individuals can purchased different condoms for vaginal, anal or 
oral sex (Smith, 1998).  
It is important to not reuse the condoms after first usage, to change condoms after 
30 minutes of intercourse, check expiration dates regularly, store properly, and don’t use 
along with female condom (Brown, 2012). You do not want to use with the female 
condom because it cause friction and slippage (Brown, 2012).  
Female condoms are a plastic pouch where one end is closed, while the other end is open 
and spanning the entire vagina (Planned Parenthood, n.d.). It provides protection from 
STDs such as HIV and leads to a decrease in there incidence rates (Holden, 2008). The 
female condom is not very accessible due to the lack of availability. It has been shown to 
provide women with a sense of empowerment by having an edge in their ability to 
negotiate for safer sex, increasing their sense of control and safety during sex. The 
condom is preferred more than the male counterpart because it increases flexibility with 
timing of wearing and taking off, and it provides a more natural feel (Holden, 2008).  
 It can also be referred to as femidom® and is strong, soft, and can be made of 
polyurethane plastic or nitrile (Dyk, 2008). The polyurethane material allows for the use 
of oil-based or water based lubricants, high temperatures, and high humidity because they 
won’t break down the material, unlike latex.  The material allows it to be stored 
anywhere unlike the latex in the male condom. The design is very unique in that it has 
two flexible rings, one at the closed end that is inserted into the vagina and the other at 
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the open end which remains outside of the vagina and spreads over the external genitalia. 
The pouch spans the same length as the male condom and is also a onetime use only 
product. It can be inserted hours before intercourse and can be left in place several hours 
after for repeated use (Dyk, 2008).  
The condom provides extra protection because it can be used during a woman’s 
menstrual cycle and it covers the areas on the penis and vagina where STIs can easily 
enter the body (Dyk, 2008). The cons with this product is that they are normally more 
expansive, not as acceptable or accessible (Dyk, 2008). This product is not meant to 
replace the male condoms, but to be an available market option. 
Fertility awareness is based on the charting of a women’s monthly cycle to avoid the 
ovulation week.  This is based on the life span of the egg and sperm. Since the egg can 
live for a day and the sperm for 6, you then have five days before ovulation, the day of 
ovulation, and a day or two after ovulation (Planned Parenthood, n.d.).  
Outer course is any sexual activity with or without vaginal intercourse. This means no 
oral, anal or vaginal penetration (“Planned Parenthood,” n.d.).  
Permanent Birth Control Method 
There are three permanent sterilization methods that are used to ensure that 
pregnancy will not occur. They consist of tubal ligation and transcervical sterilization, 
which are both conducted on a female, as well as vasectomy done on males. These 
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methods have all shown to have a failure rate of less than one percent, resulting is an 
accurate birth control method. 
Tubal ligation,  also known as tying of tubes, is a procedure carried out by a physician in 
office. The surgery must be performed when the patient is at the end of her menstrual 
flow but before the ovulation time period (Korenbrot, 1981). There are three ways to 
performing a tubal ligation, either abdominally (also known as the Pomeray technique), 
vaginally, or endoscopic (Laparoscopic technique). They can be done at the time of 
abortion, after delivery, or when not pregnant (Korenbrot, 1981).  
The physician provides both a local and general anesthesia and makes an incision 
less than one centimeters under the umbilicus through a laparoscopy technique (Pillitteri, 
2013). A lighted laparoscopy is placed into the incision and pump in carbon dioxide in 
order to lift the abdominal wall upward. This allows for the belly to be out of the physical 
line of vision and allows them to view the fallopian tube. Once this is obtained there are 
three ways to block the fallopian tube and stop the passage of the sperm or the ova 
(Pillitteri, 2013).  
The first method is to pump an electrical current through the tube for three to five 
seconds to coagulate the tissue (Pillitteri, 2013). The second is to clamp the tubes with 
either plastic, metal or rubber rings and then cut. The last method is to fill a portion of the 
tubes with a silicone gel to block flow. Either three can lead to the same result, lack of 
pregnancy. After the procedure, the patient can be discharged from the hospital within a 
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few hours. Surgical side effects within 24 hours include abdominal discomfort, bloating, 
and sharp shoulder pains (due to gas) until carbon dioxide is absorbed. There could also 
be bowel perforation and hemorrhage from the surgery (Pillitteri, 2013).  
Side effects from the surgery include changes to the ovaries blood supply( which 
can result in an increased risk of starting menopause earlier (due to blood supply being 
compromised)), a somewhat protectiveness against ovarian cancer and post-tubal-ligation 
syndromes (Pillitteri, 2013). These syndromes consist of an increase in menstrual 
cramping, irregular periods, and heavier bleeding which all can occur if the patient was 
on the pill prior to procedure (Pillitteri, 2013). The risk of death from this procedure is 
less than those of hysterectomy but there is a 0.05 to 0.10 percent chance for a health 
women 35 years old (Korenbrot, 1981). These women also have a 5 to 10 chance of 
subsequent pregnancies.  
Transcervical Sterilization- this method does not involve surgical incisions and 
general anesthesia and is sometimes referred to as Essure®. The Essure® 
technique was approved by the FDA in 2002 to provide a less invasive option for 
patients (King, Brucker, Kriebs, & Fahey, 2013). It can be done as an outpatient 
or office setting without general anesthesia or prolonged hospital admission. What 
generally occurs is a device is insert in through the vaginal and travel to the 
fallopian tubes (Figure 4).  This device contains polyester fibers within micro 
inserts that create an irritation and growth of new tissue that results in a 
permanent occlusion of the tubes. The micro inserts are small metal springs that 
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are placed at the proximal end of each tube. When released they expand and 
anchor to the tube. This overtime creates a scar tissue that leads to the occlusion 
of the fallopian tube (King et al., 2013).  
 
 
Figure 4: Tubal Ligation. Shown is the steps on how tubal ligation using the Essure® method occurs 
(King et al., 2013). 
 
Vasectomies are the most popular form of male sterilization (Pollard, 2011). They are 
done by an urologist. A vasectomy occurs when the physician makes a small incision and 
gives a local anesthetic to the scrotum area. In this procedure they locate the vas deferens 
which functions as a passage avenue for sperm to then be released. The physician 
attempts to remove a section of the vas deferens but cutting and blocking off the route. 
This blockage can be done by using a combination of titanium clamps and scarring of 
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tissue.  It is important to note that the vas deferens has been known to regenerate, in order 
to fully prevent the fallopian tubes need to be cauterized (burned) using electricity 
(Pollard, 2011). The failure rate is less than one percent but requires several months to 
achieve full contraceptive efficiency (Chao, Page, & Anderson, 2014). It should also be 
noted that reversal of the procedure can be costly and unreliable (Chao, Page, & 
Anderson, 2014).  
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CURRENT STUDIES 
Vaginal Rings 
 The use of vagina rings has been proven as an effective contraceptive that can 
provide a good inhibition of ovulation (Table 1) (Titia, Mulders, & Dieben, 2001).  
Table 1:  Contraceptive efficacy and ovulation inhibition. Shown is the currently approved or under 
investigation of vaginal rings.  (Johansson & Sitruk-Ware, 200) 
 
 
 
 
Roumen et al., reported only six pregnancies occurring in their population of 1145 
women treated with the etonogestrel-containing ring, three of these pregnancies were in 
women who had clearly violated compliance criteria during the cycle of conception 
(Roumen, Apter, Mulders, & Dieben, 2001). Weisberg et al.  reported no pregnancies in 
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either of the two trials of the NETA/EE ring used for 60 and 61 women (Weiserg et al., 
1991). Combined oral contraceptives, IUD’s and contraceptive implants have unwanted 
pregnancy rates of 0.1%, 1.5 to 0.6%, and 0.5% in the first year of use, respectively 
(Weisberg et al., 1999). 
 The most common schedule is the three week in/ one week out (Johansson & 
Sitruk-Ware, 2004). The ring is inserted in the vagina on day five of the menstrual cycle 
and left in place for three weeks. The following ring (week four) the ring is removed for 
withdrawal bleeding. The old ring can then be discarded and a new one reinserted or the 
same ring can be reinserted after a one week break. It is important to note that a specific 
day and hour must be chosen for insertion and withdrawal to avoid confusion (Johansson 
& Sitruk-Ware, 2004).  
To avoid bleeding issues researchers have used the 26 days on and four days out 
schedule (Johansson & Sitruk-Ware, 2004). Others have used methods that are based on 
the insertion of bleeding, signals where the ring is inserted and removed only when 
menstrual bleeding begins. The ring then remains out for four days and is reinserted at 
that point whether bleeding has stopped. However, this method has shown to lead to an 
irregular bleeding pattern (Johansson & Sitruk-Ware, 2004).  
 Researchers have also tried to gather ways to accurately balance the hormone 
levels that are released from the ring (Johansson & Sitruk-Ware, 2004). In the ring with 
NES only delivery the experimental rate for ovulation suppression was 50, 75, or 100 
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µg/day. This dosage method leads to a high rate of ovulation suppression.  With 100µg/ 
day having 1.2% of the cycles studied showed little to no luteal activity (Table 2). In the 
ring combined with EE and NES, the delivery rate was 150 µg/day, which showed a high 
percentage of ovulation suppression with good bleeding pattern and few side effects 
(Johansson & Sitruk-Ware, 2004).  
 
Table 2:  NES Rings:  Percent of Total Cycles with no Luteal Activity.  Samples were measured at 50, 
75 and 100µg/d. ( Johansson & Sitruk-Ware, 2004). 
 
 
 
  A recently approved ring combination with etonogestrel (active derivative of 
deogestrell) and EE (Nuvaring®, Organon USA) was evaluated and found that the 
bleeding pattern in the experiment varied when compared to the regular cycle (Johansson 
& Sitruk-Ware, 2004). In the study with NES- containing combination ring it was 
associated with good bleeding control with the period of menstrual bleeding being less 
than one week (Johansson & Sitruk-Ware, 2004). In the experiment with the etonogestral/ 
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EE ring carried out by Roumen et al., irregular bleeding occurred at a rate of only 2.6% to 
6.4% (Roumen et al., 2001). This consisted of primary spotting with breakthrough 
bleeding reported in only 0.4% to 1.1% of cycles (Johansson & Sitruk-Ware, 2004). 
Withdrawal bleeding (with one week of treatment) occurs in only 5.4 to 7.4 % of cycles 
and was absent in 0.6 to 0.2 % of treatment breaks. The duration of withdrawal bleeding 
being 4.7 to 5.3 days (Johansson & Sitruk-Ware, 2004).  
Copper IUD and Emergency Contraception Levonorgestrel 
 In a study evaluating a total of 7,034 patients there were only 10 pregnancies with 
a failure rate of only 0.14 percent (Koyama et al., 2013). Some evidence showed that 
copper IUDs are more effective if they contain at least 380mm
2
 of copper. It can be the 
only form of Emergency contraception (EC) that can provide an ongoing contraception 
for years when left in place. It requires expertise and equipment necessary for insertion. 
Side effects include pain during the insertion process and increases menstrual bleeding. If 
discomfort occurs, the use of non-steroidal anti-inflammatory drugs (NSAIDs) and local 
anesthesia are commonly utilized if discomfort if experienced during the procedure 
(Koyama et al., 2013). 
 Studies have found that with the use of the emergency contraceptive pill LNG, it 
can lead to an increase in the amount of glycodelin in the body which prohibits 
fertilization after ovulation occurs (Koyama et al., 2013). After ovulation occurs LNG has 
only minor effects on corpus luteum function and is thought to be ineffective after 
fertilization occurs. This can be proven in experiments with rats and monkeys where 
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studies indicate little fertilization problems by LNG. Researcher generally agree that 
LNG does inhibit ovulation (Koyama et al., 2013).  
A trail experiment done on the LNG pill versus the Yuzpe® method (an earlier 
regimen which consisted of higher doses of estrogen/ progesterone combination oral 
contraceptives) using 1998 women in a double-blind study, indicated that pregnancy rates 
were quite low with the use of LNG (Koyama et al., 2013). The data showed pregnancy 
rate being 1.1% in the LNG group and 3.2% in the Yuzpe® group with a yielding relative 
risk of 0.36. If used within 72 hours of intercourse the efficacy for LNG was 85% vs the 
counterpart, Yuzpe® with 52% (Table 3) (Koyama et al. 2013).  
When estimating the conception probability efficacies of LNG, researchers have 
found that it decreases with time from 95% at 24 hours to 58% within 48-72 hours 
(Koyama et al., 2013). This finding showed that early administration of LNG is 
imperative to the efficacy of the pill. To guarantee accurate results, the recommended 
time is within 72 hours, even though it can be used between 72 to 120 hours after sex. 
However, LNG has been proven ineffective once fertilization has occurred (Koyama et 
al., 2013). 
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Male Birth Control 
  The idea that prevention of pregnancy can only be targeted for only women has 
been thrown out due to the new feminist movement. There have been many research 
conducted on birth control methods for women but for a man the methods are limited 
with the use of the condom and vasectomy. Within the last 20 years there has been a shift 
and a push for male contraceptives. Researchers have attempted to evaluate several 
methods in limiting a male’s sperm count (oligospermia) or to completely cause 
infertility (Table 4 ) (Chao, Page, & Anderson, 2014). There have been many obstacles in 
producing a drug that can be fully reversible, safe for long term use, and render a male 
infertile (Chao et al., 2014).  
Table 4: Causes of male infertility. Shown is the infertility chart based on semen analysis. (Becker, 2001) 
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So far condoms use have shown to have high failure rates (with 12 out or100 
couples conceiving in the first year of use) and inconsistent usage (Chao et al., 2014). 
There have been several drugs tested on mice and other mammals that are either 
hormonal or non-hormonal.  Hormonal drugs work by suppressing the hypothalamic-
pituitary-gonadal axis to stop spermatogenesis (Figure 5). This can occur through the 
bodies’ use of gonadotropin-releasing hormone (GnRH). GnRH is secreted from the 
hypothalamus and travels to the pituitary to trigger the release of the hormone FSH 
(follicle stimulating hormone) and LH (Luteinising hormone) into the blood circulation. 
The LH in males stimulate Leydig cells of the testes to produce testosterone and the FSH 
stimulates the Sertoli cells to support spermatogenesis (Chao et al., 2014).  
 
Figure 5: The hormone basis of male contraception: Shown below is the pathway of 
spermatogenesis. (Chao et al., 2014)  
 41 
 
 
Both hormones are required to produce sufficient amounts of sperm(Chao et al., 
2014). If pathway is hinder or suppress, it can lead to a man to become azoospermia 
(infertile) or have low sperm in ejaculate (Table 4). To suppress the product in of GnRH, 
LH, or FSH, one must administer exogenous testosterone (Chao et al., 2014). This in turn 
causes a reversible inhibition on endogenous testosterone production and 
spermatogenesis (Becker, 2001).  
With the dosing of these types of hormones, one must be able to maintain serum 
and testosterone levels and extend androgen action at target tissue within a normal 
physiological range (Chao et al., 2014). Androgens with or without progesterone or 
GNRH analogues can be used to suppress endogenous gonadotropin and sperm 
production (Becker, 2001). It is absolutely required to both suppress gonadotropin 
secretions and replace endogenous testosterone suppressed by other agents (Becker, 
2001).  
Table 5: Semen Characteristics. Shown below is the various concentration of semen. (Becker, 2001)  
 
The hormonal agent first used to create these results was testosterone enanthate. 
This hormone was reversible and effective in provide a contraceptive regime (Becker, 
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2001). Researchers found that 65 percent of test subjects became azoospermic, 30 percent 
had oligospermia, and 0 to 0.8 pregnancies out of 100 per year resulted and had an 
efficacy rate of 99% (Chao et al., 2014). They also saw no serious side effects. What 
resulted was acne, weight gain, a decrease in testicular volume, an increase in 
haemoglobin and a 10 to 15 percent decrease in HDL levels.  The researcher did however 
find that there was a delay in effectiveness (3-4 months), potential fertility reversal, and 
inconvenient weekly injection became a problem (Chao et al., 2014).  
 Other studies were conducted using testosterone undecaonate, testosterone pallets, 
patches, shots, gels etc… With the undecaonate drug, one dose was given every 10 to 12 
weeks (Chao et al., 2014). Studies showed that 208 out of 299 men either developed 
azoospermia or oligospermia (less than 3 million sperm/ml) with 96.7 percent 
effectiveness. They saw a slower recover time for spermatogenesis when compared to the 
testosterone enanthate but side effects were similar. In the study with the testosterone 
pallets researchers found that it delivered a steady concentration, but need replacement 
every 3-6 months and needed to be combined with the etonogestrel implant. The 
transdermal testosterone (patch) found that it was not effective in 50 percent of men 
because of the delivery concentration (Chao et al., 2014).  
 The non-hormonal method aimed to disrupt spermatogenesis or sperm-egg 
interaction by interfering with sperm motility, testicular targets, and epididymal targets 
(Chao et al., 2014). A non- hormonal example for inhibiting sperm motility or sperm-egg 
fusion is 3-phosphate dehydrogenase-S or GAPDS. GAPDS is an enzyme that is specific 
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for sperm glycolysis. With this enzyme blocked sperm consumption of ATP is hindered. 
Studies done on mice found that infertility and a shorter contraceptive action resulted 
with the use. An example of a testicular target is JQ1, which is a molecule inhibitor of 
testis-specific bromodomain (BRDT) an epigenetic reader protein. BRDT is essential for 
chromatin remodeling during spermatogenesis. Results showed a complete or reversible 
contraceptive agent in mice and found the drug to have an apparent toxicity (Chao et al., 
2014).  
 HE6 and CRISP-1 have been shown to be epididymal targets in male 
contraceptives (Chao et al., 2014). HE6 displays an epididymis-specific expression 
pattern that has been studied in mice. This experiment showed to result in a defect in the 
reabsorption of testicular fluids in the efferent epididymal ductals. CRISP-1 however is a 
glycoprotein that is secreted by the epididymal epithelium. In experiments done on rats it 
was show for CRISP-1 to suppress the sperm capacitation and inhibit sperm-egg fusion 
(Chao et al., 2014).  
Health Care –Affordability 
There has been an increasing need for control of the world and national 
population size. A few years ago the idea of birth control was considered to be offensive 
or taboo but now with the earths limiting resources and space the issues has become 
acceptable to talk about (JAMA,  2014). All groups (including Roman Catholic Church) 
agree that parenthood should be for those that can responsibly care for children. A child 
should not be brought into the world if they cannot be loved, educated or wanted. They 
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also agree that unintended pregnancies tend to result social problems such as illegal 
abortions, desertion, despair, and hopeless poverty (JAMA, 2014). 
Nearly 49 percent of all pregnancies are unintended (Trussell et al., 2013). The 
reason is because of their lack of adherence to contraceptive use. This results in the total 
cost to U.S. taxpayer of 9.6 to 12.6 billion dollars per year. If adherence is high, the risk 
of unintended pregnancies (UP) would be significantly lower, but due to real world 
situation that is not always possible (Trussell et al., 2013). Studies show that 23% of 
minority women reported that they were unable to visit a doctor due to cost, lack of child 
care, etc as compared with 15% of white women (Table 5) (Majority Staff of the Joint 
Economic Committee, 2011). Also, 26% Native American and 27% Hispanic reported 
the same due to prohibitive cost (Committee, 2011). 
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Table 6: Income. Shown is the various reason for not going to the doctors based on income levels 
(Majority Staff of the Joint Economic Committee, 2011). 
 
.  
The 2010 Federal Medicaid reform stated that women of low-income shall have 
the same choices for family services (Winter, 2013). The women qualifying for medical 
assistance were covered based on four situations. The first was there access to 
contraception services (including abortion), the prescription birth control option, and 
availability of the morning after pill and lastly access to clinics (Winter, 2013). The U.S 
Patient Protection and Affordable Act promoted funding for family planning services 
(Chuang et al., 2012). Since then coverage has become a standard practice for private 
insurance and federally funded insurance programs (Chuang et al., 2012).  
Also, along with this President Obama upheld the Hyde Amendment which 
continued the ban on federal funds for abortion in the context of health reform (Chuang et 
al., 2012). The Affordable Care Act (ACA) or Obama Care requires private health plans 
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to cover contraceptive methods, services, and counseling without the out-of-pocket fee 
(Sonfield, Tapales, Jones, & Finer, n.d.). It also changed patients cost sharing, which has 
the potential to eliminate cost as a reason for choosing one method of contraception over 
the other. The ACA provided religious affiliated non-profits an accommodation under 
which they are supposed to be absolved from involvement in covering contraception. It 
however states that employees and family members must receive coverage through the 
insurance company (Sonfield, Tapales, Jones, & Finer, 2015.). 
Twenty-eight out of the fifty states have regulation for requiring private insurers 
to cover contraceptives (Chuang et al., 2012). Physicians have been a firsthand witness to 
the consequences of restricted access to family planning services but their voices have 
been unheard. They endorse insurance coverage and public funding for contraceptives 
and abortion services (Chuang et al., 2012). 
Children of UP are known to have worse health and long term outcomes than 
children from planned pregnancies (Burlone et al., 2013). It has been shown that by 
providing contraception’s, it can help to reduce cost-effective and cost-saving use of 
public funds (Burlone et al., 2013).  
Data show that there is a huge difference in access between economic income 
statues. Women who can afford private physicians are adequately informed and 
instructed on various birth control methods and are provided with contraceptive supplies 
(“Birth control in comprehensive health care,” 2014). Meanwhile, indigent women have 
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to visit public health and welfare agencies and are discriminated against and denied 
services.  There are several reason behind these differences. In some cases, services are 
prohibited by regulation or local statures in tax supported health facilities and are omitted 
from social welfare programs or excluded from public hospitals. Other reasons are due to 
physicians and public health official act in deference to the law due to a fear of criticism 
or fear of stirring up controversy (“Birth control in comprehensive health care,” 2014).  
Unintended pregnancy are five times more likely in poor women than in affluent 
women and can impact a women’s health, prospect for education, and impose financial 
burden on families and society (Laliberté et al., 2014). Children of unintended 
pregnancies are known to have worse health and long term outcomes than children from 
planned pregnancies (Burlone et al., 2013). It has been shown that by providing 
contraception, it can help to reduce cost-effective and cost-saving use of public funds 
(Burlone et al., 2013).  
The Affordable Care Act wants to expand Medicaid coverage to low income 
Americans because even though it may be costly in some states, it could lead to a 
potential cost-offset (Laliberté et al., 2014). This is due to the provision of contraceptives 
which result in fewer pregnancies (Laliberté et al., 2014). 
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DISCUSSION 
 
Birth control usage has become a trendy topic in today’s society. There are many 
forms and methods of contraception that can greatly impact a woman’s life. Even though 
there are many opinions that are against its usage, it has been proven to be effective in 
reducing the number of unintended pregnancies and decreasing the risks of sexual 
transmitted diseases. Most options like the shot, implant, and patch, provide a way to 
rapidly get the protection that is needed. However, many require a certain amount of time 
to become effective.  
All methods described within this thesis can provide an efficient way to protect 
oneself from getting pregnant but not all can protect against acquired disease from sexual 
intercourse (Figure 6). Figure 6 below is a summary of the birth control options listed as 
the least to the most effective.  According to the CDC just using a spermicide is not 
efficient in prevent against pregnancy, it must be used in conjunction with another type of 
protection. The most effective forms of contraceptive are the IUD, implants and 
sterilization (both male and female) with risk of pregnancy being less than one percent. 
The other methods have a high success rate but can also result in failures. 
The most effective birth control options are also the most invasive. They require 
consultation from a medical provider and can be expansive. Many women, especially 
minorities, are not informed about these options because of lack of insurance coverage.  
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There is much research being conducted on ways of improving the already 
available birth control options.  One such approach is through the development of an 
effective male contraceptive option. However, to fund the projects it sometimes requires 
government subsides. Many religious groups and local states are against using public 
money to further advance birth control contraceptives. The Affordable Care Act helps to 
ensure that uninsured women can be covered for any contraceptive method of their 
choosing. Since passing the bill, many minorities for the first time can receive and afford 
medical care and are being informed on options for prevention.  
 
CONCLUSIONS 
Contraceptives are a needed protection if one is going to part take in sexual 
activities. Being able to distinguish between the various methods can help a women to 
make a proper and educated decision on which method is right for her. It is important that 
healthcare providers, spouses, partners and parents be able to have an open dialogue 
about birth control usage.  It is important for women to know that inconsistent use and 
non-use of contraception contribute to high rates of unintended pregnancies. Minorities 
(Black and Hispanic women) are especially at a higher risk of these events and should be 
informed of the risk associated with noncompliance.  Intervention to ensure counseling 
and information exchange during health care visits can increase a women’s ability to 
make an informed decision  
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